At the heart of the Toulouse Oncopole, patient care will be centred around an innovative clinical department where all Claudius Regaud Institute's teams and equipment will be located. Partners of this project are the Centre Hospitalier Universitaire (CHU), private clinics and the liberal medical sector, the Etablissement Français du Sang, the regional cancer network ONCOMIP, and the University and General Hospitals. The organisation of this 60000 m2 centre enables professionals to easily communicate with each other. It is focussed on providing the latest treatments and represents the future for oncology centres.
With 306 beds, this clinical centre brings together all the means necessary for rapidly transferring research advances to the patient's bed. The centre treats all cancers and relies on established fields of expertise at the Claudius Regaud Institute and at the university hospital of Toulouse: hematology, gynaeco-senology, melanomas, digestive and upper aero-digestive tract cancers.
In 2014, the Claudius Regaud Institute will settle in the Institute universitaire du cancer.
The objectives of this medical-scientific project are focussed on obtaining fast results in molecular modelling for a prognosis, the analysis of response biomarkers and resistance to treatments. This centre will concentrate on high tech techniques, diagnostics and treatments (scans, radiotherapy, nuclear medicine, anatomical pathology) linked to research centres (molecular and cellular imaging, biotreatments, biological resources). Toulouse will provide patients with an environment using exceptional methods and skills. The patient will be given personalised care including uncovering their genomic profile and their micro environment and analysing each stage of the their care including after the cancer has been treated.
An Outpatient Pluridisciplinary Evaluation Centre
As a resort consultations centre, it will group together the expertise of the whole Institut universitaire du cancer’s partners in every oncology disciplines. The patient could be sent to it by his first care structure for specific or complex pathologies. He will be received in the frame of a consultation gathering several specialists (radiotherapist, medical oncologist, surgeon…) from the different partner structures. The main objective is to give him the soonest possible a refined diagnosis, a treatment plan and an orientation towards the structure the most adapted to his care.
A mutual hospitalisation platform comprising 306 beds and rooms
A clinical research unit at the heart of the system
For a cancer patient, taking part in a therapeutic trial guarantees a good care quality because it enables to benefit quickly from research advances, concerning new molecules or new equipment. The « Clinique universitaire du cancer » will be provided with a clinical research unit, in charge of therapeutic trials’ coordination. The unit will lean on :
Diagnostic and therapeutic technical platforms shared between partners
Research and innovation platforms
In addition to the clinical research unit, the Institut universitaire du cancer will be provided with research and innovation platforms that will be used by the whole care and research partners :